Pioneering French oncologist Mathe dies at 88

Oct 18, 2010

(AP) -- Oncologist Georges Mathe, who in 1959 performed the world's first bone marrow transplant, has died, the French president's office said Monday. He was 88.

Nicolas Sarkozy's office said Mathe died on Friday, but did not provide any additional details.

"His contribution to the progress of remains major," the statement said. "In 1959, he performed the first bone marrow transplants on six Yugoslav physicians who had been accidentally irradiated at a nuclear power plant. Four of them survived."

Mathe was the first physician to use bone marrow transplantation to treat leukemia. The procedure involves giving patients a high dose of and radiation to kill cells. Transplanting bone marrow is also used to treat radiation and blood diseases including sickle cell anemia.

Mathe founded a specialized cancer center in the Paris suburb of Villejuif in the early 1960s and ran its blood disease unit until 1990, the statement said.

Explore further: How removing a protein slows blood vessel growth in tumors

0 shares

Related Stories

Research shows cord blood comparable to matched bone marrow

Jun 08, 2007

University of Minnesota researchers report that umbilical cord blood transplants may offer blood cancer patients better outcomes than bone marrow transplants, according to an analysis of outcome data performed at the Center ...

Molecule dictates how stem cells travel

Jan 14, 2006

U.S. researchers have defined a molecule that dictates how blood stem cells travel to the bone marrow and establish blood and immune cell production.

Recommended for you

Live imaging reveals how wound healing influences cancer

43 minutes ago

Researchers in the United Kingdom and Denmark have studied the "see-through" larvae of zebrafish to reveal how wound healing leads to skin cancer. Live imaging shows neutrophils, the protective inflammatory cells of the body's ...

Protein's impact on colorectal cancer is dappled

14 hours ago

Researchers at University of California, San Diego School of Medicine have discovered a cell signaling pathway that appears to exert some control over initiation and progression of colorectal cancer, the ...

Colon cancer: Taking a step back to move forward

23 hours ago

Recent Weizmann Institute studies are revealing a complex picture of cancer progression in which certain genes that drive tumor growth in the earlier stages get suppressed in later stages - taking a step ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.